T
MRTX

TOBAM’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

TOBAM’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-112,901
Closed -$7.88M – 455
2022
Q3 		$7.88M Buy
112,901
+63,164
+127% +$4.67M 0.55% 56
2022
Q2 		$3.34M Buy
+49,737
New +$3.16M 0.21% 84
2021
Q2 		– Sell
-160
Closed -$27K – 450
2021
Q1 		$27K Hold
160
– – ﹤0.01% 420
2020
Q4 		$35K Buy
+160
New +$34.6K ﹤0.01% 388

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return